Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenQuadfi Safety in Healthy Infants
NCT03673462Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2018
- Primary completion
- Mar 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of meningococcal A conjugate vaccine in meningococcal infection, sponsored by Sanofi. Started Sep 2018; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT03673462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03673462.